Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Stendörren in connection with a tap issue of SEK 300 million bonds
Mandate

Vinge has advised Stendörren in connection with a tap issue of SEK 300 million bonds

October 04, 2018 Banking and Finance

Vinge has advised Stendörren Fastigheter AB (publ) (“Stendörren”) in connection with a tap issue of SEK 300 million senior unsecured floating rate bonds. 

The bonds have a tenor of three years and a floating interest rate of three months Stibor plus 4.25 per cent. The proceeds from the subsequent bond issue will be issued for general corporate purposes. Swedbank has acted as Issuing Agent and financial advisor to Stendörren.

In accordance with the terms and conditions, the subsequent bonds are intended to be listed and admitted to trading on the corporate bond list at Nasdaq Stockholm shortly.

Vinge also advised Stendörren in connection with the company’s initial bond issue of SEK 350 million on 18 June 2018. A listing prospectus was approved by the Swedish Financial Supervisory Authority on 1 August 2018.

Vinges team consisted of Louise Brorsson Salomon, André Isacson and Fredric Reissmüller.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025